|
| | Publication Year | Title | Author(s) |
| 1 | May-2023 | Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. | Manos, Kate ; Chong, Geoffrey ; Keane, Colm; Lee, Sze Ting ; Smith, Charmaine; Churilov, Leonid ; McKendrick, Joseph; Renwick, William; Blombery, Piers; Burgess, Melinda; Nelson, Niles Elizabeth; Fancourt, Tineke ; Hawking, Joanne; Lin, Wendi; Scott, Andrew M ; Barraclough, Allison ; Wight, Joel C ; Grigg, Andrew P ; Fong, Chun Yew ; Hawkes, Eliza A |
| 2 | 3-Mar-2023 | Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinaemia: patient outcomes and impact of bendamustine dosing. | Arulogun, Suzanne O; Brian, Duncan; Goradia, Harshita; Cooney, Aaron; Menne, Tobias; Koo, RayMun; O'Neill, Aideen T; Vos, Josephine M I; Pratt, Guy; Turner, Deborah; Marshall, Kirsty; Manos, Kate ; Anderson, Claire; Gavriatopoulou, Maria; Kyriakou, Charalampia; Kersten, Marie J; Minnema, Monique C; Koutoumanou, Eirini; El-Sharkawi, Dima; Linton, Kim; Talaulikar, Dipti; McCarthy, Helen; Bishton, Mark; Follows, George; Wechalekar, Ashutosh; D'Sa, Shirley P |
| 3 | 21-Apr-2022 | Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients. | Wilson, Matthew R; Eyre, Toby A; Kirkwood, Amy A; Wong Doo, Nicole; Soussain, Carole; Choquet, Sylvain; Martinez-Calle, Nicolás; Preston, Gavin; Ahearne, Matthew; Schorb, Elisabeth; Moles-Moreau, Marie-Pierre; Ku, Matthew; Rusconi, Chiara; Khwaja, Jahanzaib; Narkhede, Mayur; Lewis, Katharine L; Calimeri, Teresa; Durot, Eric; Renaud, Loïc; Øvlisen, Andreas Kiesbye; McIlroy, Graham; Ebsworth, Timothy J; Elliot, Johnathan; Santarsieri, Anna; Ricard, Laure; Shah, Nimish; Liu, Qin; Zayac, Adam S; Vassallo, Francesco; Lebras, Laure; Roulin, Louise; Lombion, Naelle; Manos, Kate ; Fernandez, Ruben; Hamad, Nada; Lopez-Garcia, Alberto; O'Mahony, Deirdre; Gounder, Praveen; Forgeard, Nathalie; Lees, Charlotte; Agbetiafa, Kossi; Strüßmann, Tim; Htut, Thura Win; Clavert, Aline; Scott, Hamish; Guidetti, Anna; Barlow, Brett R; Tchernonog, Emmanuelle; Smith, Jeffery; Miall, Fiona; Fox, Christopher P; Cheah, Chan Y; El Galaly, Tarec Christoffer; Ferreri, Andrés J M; Cwynarski, Kate; McKay, Pamela |
| 4 | 7-Jan-2022 | Timing of high dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1,384 patients. | Wilson, Matthew R; Eyre, Toby Andrew; Kirkwood, Amy A; Wong Doo, Nicole; Soussain, Carole; Choquet, Sylvain; Martinez-Calle, Nicolás; Preston, Gavin; Ahearne, Matthew J; Schorb, Elisabeth; Moles-Moreau, Marie-Pierre; Ku, Matthew; Rusconi, Chiara; Khwaja, Jahanzaib; Narkhede, Mayur; Lewis, Katharine Louise; Calimeri, Teresa; Durot, Eric; Renaud, Loïc; Øvlisen, Andreas Kiesbye; Mcilroy, Graham; Ebsworth, Timothy John; Elliot, Johnathon; Santarsieri, Anna; Ricard, Laure; Shah, Nimish; Liu, Qin; Zayac, Adam Stephen; Vassallo, Francesco; Lebras, Laure; Roulin, Louise; Lombion, Naelle; Manos, Kate ; Fernandez, Ruben; Hamad, Nada; Lopez-Garcia, Alberto; O'Mahony, Deirdre; Gounder, Praveen; Forgeard, Nathalie; Lees, Charlotte; Agbetiafa, Kossi; Strüessmann, Tim; Htut, Thura Win; Clavert, Aline; Scott, Hamish; Guidetti, Anna; Barlow, Brett R; Tchernonog, Emmanuelle; Smith, Jeffery; Miall, Fiona; Fox, Christopher P; Cheah, Chan Y; El Galaly, Tarec Christoffer; Ferreri, Andrés J M; Cwynarski, Kate; McKay, Pamela |
| 5 | 4-Aug-2021 | Safe administration of obinutuzumab to rituximab-intolerant patients. | Manos, Kate ; Grigg, Andrew P |
| 6 | Jul-2021 | Systemic ALCL Treated in Routine Clinical Practice: Outcomes Following First-Line Chemotherapy from a Multicentre Cohort. | Martinez-Calle, Nicolas; Kirkwood, Amy A; Lamb, Maxine; Smith, Alex; Khwaja, Jahanzaib; Manos, Kate ; Shrubsole, Caroline; Gray, Nicola; Lewis, Katharine; Tivey, Ann; Bishton, Mark J; Hawkes, Eliza A ; Ahearne, Matthew J; Osborne, Wendy; Collins, Graham P; Illidge, Timothy; Linton, Kim M; Cwynarski, Kate; Burton, Cathy; Fox, Christopher P |
| 7 | May-2021 | Evolution of eligibility criteria for diffuse large B-cell lymphoma randomised controlled trials over 30 years. | Loh, Zoe ; Salvaris, Ross; Chong, Geoffrey ; Churilov, Leonid ; Manos, Kate ; Barraclough, Allison ; Hawkes, Eliza A |
| 8 | 2-Mar-2021 | Myeloid somatic mutation panel testing in myeloproliferative neoplasms. | Ross, David M; Thomson, Candice; Hamad, Nada; Lane, Steven W; Manos, Kate ; Grigg, Andrew P ; Guo, Belinda; Erber, Wendy N; Scott, Ashleigh; Viiala, Nick; Chee, Lynette; Latimer, Maya; Tate, Courtney; Grove, Carolyn; Perkins, Andrew C; Blombery, Piers |
| 9 | Mar-2021 | Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience. | Lewis, Katharine L; Chin, Collin K; Manos, Kate ; Casey, John; Hamad, Nada; Crawford, Julie; Ho, Shir-Jing; Issa, Samar; Grigg, Andrew P ; Wood, Peter; Gandhi, Maher K; Do, Bryan; Nastoupil, Loretta; Hawkes, Eliza A ; Cheah, Chan Y |
| 10 | 2021 | Outcomes of non-myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission. | Nguyen, Phillip C; Manos, Kate ; Fong, Chun Y; Schwarer, Anthony P ; Tiong, Ing S ; Wei, Andrew H; Kliman, David; Curtis, David J |
Loading...
2
0
20
0
false